HIV/AIDS Treatment
Updated federal guidelines recommend additional first-line therapy for HIV
Published in AIDS Weekly, December 13th, 2004
Retrovir and Epivir are available as Combivir (lamivudine and zidovudine), which delivers a fixed-dose combination of both NRTIs in a single tablet taken twice daily (BID) with or without food. The recommendations, developed by the U.S. Department of Health and Human Services (DHHS), were recently updated and published (October 29, 2004).
Dual nucleoside combinations are the most frequently used foundation of combination...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-12-13)
More Articles from AIDS Weekly
- HIV/AIDS Healthcare
HIV-1 genotype/virtual phenotype correlate for predicting PI/NNRTI resistance - HIV/AIDS Research
Galantamine and nicotine inhibit HIV-1 gp120-induced microglial activation - HIV/AIDS Research
RTF prevents bystander T-cell death associated with HIV infection - HIV/AIDS Treatment
Zidovudine forms DNA adducts in treated HIV-infected patients - HIV/AIDS-Associated Nephropathy
HAART helps prevent progression of pediatric HIV-associated nephropathy - AIDS/HIV Vaccine
Antigenicity of HIV-1 p24 produced in high yields from plants was preserved - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
